252 related articles for article (PubMed ID: 10802637)
1. Spin-offs versus start-ups as business models in biotechnology.
Persidis A; De Rubertis F
Nat Biotechnol; 2000 May; 18(5):570-1. PubMed ID: 10802637
[No Abstract] [Full Text] [Related]
2. Sunbaked biotechnology in Australia.
Littlejohn T
Nat Biotechnol; 2002 Sep; 20(9):873-7. PubMed ID: 12205502
[No Abstract] [Full Text] [Related]
3. Shutters come off IPO window.
Hodgson J
Nat Biotechnol; 2002 Jan; 20(1):6. PubMed ID: 11753342
[No Abstract] [Full Text] [Related]
4. Bioentrepreneurship around the world.
Persidis A
Nat Biotechnol; 1998 May; 16 Suppl():3-4. PubMed ID: 9591247
[No Abstract] [Full Text] [Related]
5. Divining the path to a successful European exit.
Buch HK; Gustafsson AC; Drvota V; Sundberg CJ
Nat Biotechnol; 2011 Mar; 29(3):205-7. PubMed ID: 21510008
[No Abstract] [Full Text] [Related]
6. Michigan's next wave of biopharmaceutical entrepreneurship.
Kerppola R; van de Walle M; Surine S
Nat Biotechnol; 2003 Sep; 21(9):1109-11. PubMed ID: 12949575
[No Abstract] [Full Text] [Related]
7. Europe discovers bioentrepreneurship.
Haycock P
Nat Biotechnol; 1998 May; 16 Suppl():6. PubMed ID: 9591249
[No Abstract] [Full Text] [Related]
8. Biotechnology in Ireland: hard work, money and the brain gain.
O'Neill MF
Drug Discov Today; 2007 Feb; 12(3-4):108-11. PubMed ID: 17275730
[No Abstract] [Full Text] [Related]
9. Building for an exit (or not).
Gunning TG
Nat Biotechnol; 2008 Sep; 26(9):971-3. PubMed ID: 18792427
[TBL] [Abstract][Full Text] [Related]
10. Biotech business Down Under.
Beckley C
Nature; 2004 Jun; 429(6991 Suppl):5-9. PubMed ID: 15175704
[No Abstract] [Full Text] [Related]
11. Early-stage returns?
Booth BL
Nat Biotechnol; 2006 Nov; 24(11):1335-40. PubMed ID: 17093473
[TBL] [Abstract][Full Text] [Related]
12. Today's biotech industry in India.
Suresh N
Biotechnol J; 2009 Mar; 4(3):291-4. PubMed ID: 19296434
[No Abstract] [Full Text] [Related]
13. Biotechs hold their own in shifting industry.
Mitchell P
Nat Biotechnol; 2002 Nov; 20(11):1065-6. PubMed ID: 12410238
[No Abstract] [Full Text] [Related]
14. Japanese firms broaden investment focus to early biotech.
Louët S; Sipp D
Nat Biotechnol; 2004 Aug; 22(8):931-2. PubMed ID: 15286631
[No Abstract] [Full Text] [Related]
15. Any diamonds in the diagnostic coal?
Jacobs T
Nat Biotechnol; 2006 Aug; 24(8):930. PubMed ID: 16900133
[No Abstract] [Full Text] [Related]
16. Biotech's wonder ride.
Rynecki D
Fortune; 2000 Mar; 141(5):435-6. PubMed ID: 10788046
[No Abstract] [Full Text] [Related]
17. Bugs or drugs, tortoises or hares?
Jacobs T
Nat Biotechnol; 2005 Mar; 23(3):293. PubMed ID: 15765079
[No Abstract] [Full Text] [Related]
18. The stampede to convertibles.
Jacobs T
Nat Biotechnol; 2003 Aug; 21(8):855. PubMed ID: 12894195
[No Abstract] [Full Text] [Related]
19. Biotechnology in the Medicon Valley.
Frank L
Nature; 2002 Dec; 420(6916 Suppl):A27, A29, A31 passim. PubMed ID: 12501124
[No Abstract] [Full Text] [Related]
20. China's biotech experiments.
Hepeng J
Nat Biotechnol; 2005 Dec; 23(12):1472-3. PubMed ID: 16421994
[No Abstract] [Full Text] [Related]
[Next] [New Search]
